Beijing Tong Ren Tang's controlling shareholder releases Q3 2025 financial update

Beijing Tong Ren Tang Chinese Medicine Company Limited has announced an update regarding the financial information of its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., for the nine months ended 30 September 2025. Tong Ren Tang Technologies has published unaudited financial information for this period, which is available on the Stock Exchange's website.

Additionally, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, is set to announce its unaudited results for the same nine-month period on or before 31 October 2025, on the Shanghai Stock Exchange. Shareholders and potential investors are advised to exercise caution when trading the company’s securities.

The company's board, as of 28 October 2025, includes Mr. Yan Han as chairman, Mr. Yue Zheng as vice chairman, and Mr. Wang Chi as executive directors, with Ms. Feng Li as non-executive director. Independent non-executive directors include Mr. Tsang Yok Sing, Jasper, Mr. Xu Hong Xi, and Mr. Chan Ngai Chi.